Does estrogen receptor gene polymorphism play a role in Parkinson’s disease? - 30/09/09
, Wei-Dong Cheng a, Juan Li a, Yu-Feng Zheng a, Cun-Ju Guo a, Sheng-Gang Sun b, Le-Xin Wang c, ⁎ 
Corresponding author. Tel.: +61 2 69332905; fax: +61 2 69 332587.Corresponding author. Tel.: +86 635 8276215; fax: +86 635 8277306.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
This study was designed to investigate the frequency of estrogen receptor (ER) gene polymorphism in Chinese patients with Parkinson’s disease (PD). Polymerase chain reaction (PCR) method and restriction fragment length polymorphism (RFLP) were used to detect the ER gene polymorphisms in 158 PD patients and 146 healthy controls. In the PD and control groups, “x” accounted for 83.5% and 80.8%, respectively (P>0.05). “xx” was found in 77.2% of the PD group and in 69.9% of the control group (P>0.05). The frequency of “p” in the PD and control group was 67.7% and 64.0%, respectively (P>0.05). “pp” was 51.9% in the PD group and 43.8% in the control group (P>0.05). “ppxx” was found in 49.4% of the PD and 43.0% of the control subjects (P>0.05). There was no significant difference in the “x”, “xx”, “p”, “pp” or “ppxx” between males and females within the PD or control groups. In conclusion, we found no significant differences in the genotype or allele frequencies between patients with Parkinson’s disease and healthy subjects. These findings suggest that the estrogen receptor gene polymorphism may not play a key role in the pathogenesis PD in Chinese patients.
Le texte complet de cet article est disponible en PDF.Keywords : Receptor, Estrogen, Gene polymorphisms, Parkinson’s disease, Neurology
Plan
Vol 63 - N° 8
P. 599-602 - septembre 2009 Retour au numéro
Article précédent
- Protective effects of transgene expressed human PON3 against CCl4-induced subacute liver injury in mice
- Wei Peng, Xiaoling Jiang, Lv Haiqin, Chi Zhang, Jie Zhu, Junfeng Zhang, Yuhui Zang, Junchuan Qin
- A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
- Qian Zhang, Xin-En Huang, Li-Li Gao
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?